FDA
approval
· 2021-03-04
FDA Approved: LEVORPHANOL TARTRATE — Supplemental Application (ACERTIS PHARMACEUTICALS, LLC)
Summary
FDA approved a supplemental application for levorphanol tartrate by Acetris Pharmaceuticals, LLC (ANDA211484).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVORPHANOL TARTRATE (LEVORPHANOL TARTRATE)